News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LAB21 Limited Among First to Offer FDA Approved Companion Diagnostic in the US


7/12/2012 10:34:51 AM

CAMBRIDGE, England--(BUSINESS WIRE)--Lab21 Limited, the global specialist in personalized medicine and clinical diagnostics is pleased to announce that its CLIA laboratory in Greenville, South Carolina, has been named as one of nine laboratories in the US to offer the first FDA approved companion diagnostic test to provide guidance for the use of Erbitux® (cetuximab).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES